We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
8 similar Incentive Stock Option Agreement contracts by Altimmune, Inc., Solid Biosciences Inc., Solid Biosciences, LLC
Incentive Stock Option AgreementIncentive Stock Option Agreement • March 13th, 2019 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Delaware
This Incentive Stock Option Award Agreement (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Solid Biosciences Inc., a Delaware corporation, (the “Company”) and the Participant specified above, pursuant to the Solid Biosciences Inc. 2018 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
Standard Contracts
SOLID BIOSCIENCES INC. FORM OF INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • December 29th, 2017 • Solid Biosciences, LLC • Biological products, (no disgnostic substances) • Delaware
This Option may be exercised with respect to the first 25% of the shares subject to this Option on the first anniversary date of the Grant Date and an additional 25% of the shares subject to this Option upon each subsequent anniversary date thereafter until the fourth anniversary of the Grant Date (in each case, subject to the Participant’s continued service with the Company or any of its Subsidiaries through the applicable vesting date).
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • November 9th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • November 9th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • May 8th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and